Опыт применения тебантина (габапентина) в лечении хронических дискогенных болевых синдромов шейного и поясничного остеохондроза
2007
Sixteen patients with CDPS underwent 4-8 weeks study with increasing doses of tebantin. Tebantin (Gbapentin) was initiated at 300 mg/day being increased to 1800 mg/day, and in two cases to 2700-3000 mg/day. Systemic evaluation of intensity of pain was conducted using visual-analog scale (VAS) baseline I; 4, and 8 weeks. A significant pain reduction within 4 weeks of treatment was observed. The mean weekly pain score (on VAS-scale) decreased from 6,1 to 1,0 in patients with lumbar osteochondrosis and from 7,9 to 2,6 in patients with cervical osteochondrosis. We can recommend Tebantin (Ga-bapentin) as an effective method of management of CDPS.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI